Q: I bought several stock in Nov. and Dec. one is SIS, CAE, GSY, & DND. The following is the 5%, 7%, 8.25%, & 50%+. Of those which would you sell and in which order.
Q: Should one be concerned that Alain Bedard holds all 3 positions of Chairman, President, and Chief Executive Officer. While one cannot deny that he has been very successful over the years, my concern is about governance. I also wonder about succession plans as this looks like a one man show. Please tell me why this should ( or should not) concern me enough not buy the stock. Thanks. Derek.
I know you can only generalize re portfolio makeup - I’m up 75% on this stock and it now makes up 7% of my fairly well-diversified portfolio…do you think it’d be appropriate to trim back to 5% at this point or stay in this weighting as everything I’ve read about this company seems very positive in the near term?
Q: Hi
I know that there has been lots of discussion on 5i about the cost base for Topicus when it was spun out from CSU. However, I've reviewed the questions and forums and I'm still confused. TOI has been sold in a non-registered account and now I need to determine the cost base for tax purposes. The brokerage shows $0. Is there a consensus on what the TOI cost base at spin out should be? Thanks for providing some clarity!
Q: I've been watching ECN over the past little while through 5i and note that they seem to be one of your favourite companies due to strong mgt. Noted your answers to some questions on Jan 24/25 and you felt that they have strong upside potential over the next 12-24 months. How risky would you say an investment in ECN is....say relative to a company like GSY? Thank you.
Q: I purchased AT at just over $8 for my TFSA slightly more than a couple of years ago and am down >70% since. It would need to appreciate by >350% to get me back to break-even. I have a long timeframe but given that - aside from the 6 month period between about Aug/20 and Feb/21 when the share price ramped up exponentially - AT’s historical price stays put in the +/- $2.50 price range, do you see any realistic probability of AT appreciating by magnitudes of order over the course of the next couple of years? I wouldn’t think even a buy-out/take over would provide that kind of premium. It just seems like dead money for the foreseeable future. I know you can’t personalize advice but in a similar situation (eg Growth Model Portfolio) would you take your lumps and move on or would you be inclined to continue to hold and, if so, for how long? Thanks.
Q: Hello. I already hold these 4 stocks, in a well diversified by sector, TFSA with WELL down considerably and the other 3 near break even. I have 26 stocks in my TFSA, so rather than deploying new money into an additional holding, I am considering adding to these companies. Your thoughts.
Q: There is an article this morning regarding the number of hours that Canadian doctors have to spend on doing paperwork over the course of a day. Things like insurance and income assistance forms, medical reviews for drivers and disability tax credits, etc., said to be overwhelming. Apparently some some forms are being shortened, but hope is that more technology will be used in doctor's offices to further reduce the work.
Is this an area of healthcare that WELL is involved in, or could be?
Is WELL expanding its expertise in other areas in the future - i.e. "long runway for growth" ?
Q: Ytd tsx composite index up 6.79% and tsx industrials up 2.43%
Can you explain why Byd is down .73%?
Would you be a buyer today of Byd for a 5 year hold?
Q: So I have added BN and GSY as more growth orientated stocks to my conservative ( banks, utilities, telecom, reits ) non registered account and now looking to add two of these seven names to the mix. Which look the most attractive regarding valuation, balance sheet and growth and why ? Thanks. Derek